Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis
- PMID: 20617422
- DOI: 10.1007/978-1-60761-803-4_10
Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis
Abstract
It is well established that the blood coagulation system is activated in cancer. In addition, there is considerable evidence to suggest that clotting activation plays an important role in the biology of malignant tumors, including the process of blood-borne metastasis. For many years our laboratory has used experimental models of lung metastasis to study the events that follow the introduction of procoagulant-bearing tumor cells into circulating blood. This chapter focuses on the basic methods involved in assessing the anti-metastatic effects of anticoagulants and anti-platelet agents using rodent models of experimental metastasis. In addition, it summarizes our experience with these models, which collectively suggests that intravascular coagulation and platelet activation are a necessary prelude to lung tumor formation and that interruption of coagulation pathways or platelet aggregation may be an effective anti-metastatic strategy.
Similar articles
-
Effect of antihemostatic agents on experimental tumor dissemination.Semin Thromb Hemost. 2002 Feb;28(1):29-38. doi: 10.1055/s-2002-20562. Semin Thromb Hemost. 2002. PMID: 11885023 Review.
-
Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.Thromb Haemost. 2006 Dec;96(6):816-21. doi: 10.1160/th06-05-0289. Thromb Haemost. 2006. PMID: 17139378 Free PMC article.
-
Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity.Thromb Haemost. 2005 Nov;94(5):1084-93. doi: 10.1160/TH05-04-0249. Thromb Haemost. 2005. PMID: 16363253
-
Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.J Med. 1974;5(1):7-22. J Med. 1974. PMID: 4134042 Review. No abstract available.
-
The effect of heparin and warfarin on primary and metastatic tumors.J Med. 1974;5(1):23-31. J Med. 1974. PMID: 4598770 Review. No abstract available.
Cited by
-
Do lung cancer patients require routine anticoagulation treatment? A meta-analysis.J Int Med Res. 2020 Jan;48(1):300060519896919. doi: 10.1177/0300060519896919. J Int Med Res. 2020. PMID: 31948304 Free PMC article.
-
Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs.Curr Pharm Des. 2014;20(33):5298-308. doi: 10.2174/1381612820666140128220152. Curr Pharm Des. 2014. PMID: 24479797 Free PMC article. Review.
-
Beyond the thrombus: Platelet-inspired nanomedicine approaches in inflammation, immune response, and cancer.J Thromb Haemost. 2022 Jul;20(7):1523-1534. doi: 10.1111/jth.15733. Epub 2022 May 22. J Thromb Haemost. 2022. PMID: 35441793 Free PMC article. Review.
-
Endothelial cell HIF-1α and HIF-2α differentially regulate metastatic success.Cancer Cell. 2012 Jan 17;21(1):52-65. doi: 10.1016/j.ccr.2011.11.017. Cancer Cell. 2012. PMID: 22264788 Free PMC article.
-
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.Biomaterials. 2016 Jan;76:52-65. doi: 10.1016/j.biomaterials.2015.10.046. Epub 2015 Oct 21. Biomaterials. 2016. PMID: 26519648 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
